First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge

As SARS-CoV-2 circulating variants evolve, it is important to understand the vulnerabilities of these viruses to neutralizing antibodies. Within this manuscript, we describe first-generation antibodies isolated following infection with WA-1 that retain viral neutralization to subsequent Omicron variants by targeting a site of viral vulnerability called the NTD. This work highlights the shifting landscape of SARS-CoV-2 variants and provides mechanistic insights into how antibodies from prior infections may play a role in preventing subsequent SARS-CoV-2 variant infections.

Authors

Institutions

Publication Details

Journal
mBio
Published
2025-08-29
DOI
https://doi.org/10.1128/mbio.01036-25
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge

Ningbo Jian, Tongqing Zhou, Jaime L. Jensen, Letzibeth Mendez-Rivera et al.
mBio
SARS-CoV-2 and COVID-19 Research
article

First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge

Ningbo Jian, Tongqing Zhou, Jaime L. Jensen, Letzibeth Mendez-Rivera, William W. Reiley, Agnes Hajduczki, Jeffrey R. Currier, Dominic Paquin‐Proulx, Nelson L. Michael, Vincent Dussupt, Annika Schmid, Paul V. Thomas, Victoria R. Polonis, Michael Joyce, Shelly J. Krebs, Juhi Arora, Kerri G. Lal, Gabriel L. Smith, Jean‐François Hernandez, Phyllis A. Rees, Isabella Swafford, Rajeshwer S. Sankhala, I‐Ting Teng, Natalie D. Collins, Mekhala Rao, Lauren Smith, Irene León, D B Wasson, Michelle Zemil McCrea
article en

Abstract

As SARS-CoV-2 circulating variants evolve, it is important to understand the vulnerabilities of these viruses to neutralizing antibodies. Within this manuscript, we describe first-generation antibodies isolated following infection with WA-1 that retain viral neutralization to subsequent Omicron variants by targeting a site of viral vulnerability called the NTD. This work highlights the shifting landscape of SARS-CoV-2 variants and provides mechanistic insights into how antibodies from prior infections may play a role in preventing subsequent SARS-CoV-2 variant infections.

mBioVol. 16(10)
Trudeau Institute (US), Henry M. Jackson Foundation (US), Institut de Recherche Vaccinale (FR), Walter Reed Army Institute of Research (US)
U.S. Department of Defense, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 73%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.